March 04, 2015 3:31 PM ET

Healthcare Equipment and Supplies

Company Overview of ZELTIQ Aesthetics, Inc.

Company Overview

ZELTIQ Aesthetics, Inc., a medical technology company, is engaged in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. The company sells its products through a network of distributors, as well as a direct sales force to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetics, Inc. was found...

4698 Willow Road

Suite 100

Pleasanton, CA 94588

United States

Founded in 2005

Phone:

925-474-2500

Fax:

925-474-2599

Key Executives for ZELTIQ Aesthetics, Inc.

Chief Executive Officer, President and Director
Age: 49
Total Annual Compensation: $875.0K
Chief Financial Officer, Principal Accounting Officer and Senior Vice President
Age: 41
Total Annual Compensation: $449.5K
Chief Commercial Officer and Senior Vice President
Age: 56
Total Annual Compensation: $552.5K
Senior Vice President, General Legal Counsel and Corporate Secretary
Age: 52
Total Annual Compensation: $351.9K
Compensation as of Fiscal Year 2013.

ZELTIQ Aesthetics, Inc. Key Developments

ZELTIQ Aesthetics, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Twelve Months Ended December 31, 2014; Revised Financial Guidance for the Full Year 2015

ZELTIQ Aesthetics, Inc. reported unaudited consolidated earnings results for the fourth quarter and twelve months ended December 31, 2014. For the quarter, the company reported revenue of USD 50.772 million compared to USD 35.841 million a year ago. Income from operations was USD 1.607 million compared to loss from operations of USD 5.305 million a year ago. Income before income taxes was USD 1.535 million compared to loss before income taxes of USD 5.344 million a year ago. Net income was USD 1.317 million compared to net loss of USD 5.405 million a year ago. Basic and diluted net income per share was USD 0.03 compared to basic and diluted loss per share of USD 0.15 a year ago. Adjusted net income was USD 3.118 million compared to USD 3.121 million a year ago. Adjusted EBITDA was USD 4.435 million compared to adjusted LBITDA of USD 2.284 million a year ago. For the twelve months, the company reported revenue of USD 174.478 million compared to USD 111.626 million a year ago. Income from operations was USD 2.124 million compared to loss from operations of USD 19.348 million a year ago. Income before income taxes was USD 1.762 million compared to loss before income taxes of USD 19.165 million a year ago. Net income was USD 1.531 million compared to net loss of USD 19.305 million a year ago. Basic and diluted net income per share was USD 0.04 compared to basic and diluted loss per share of USD 0.53 a year ago. Net cash used in operating activities were USD 0.856 million compared to USD 4.081 million a year ago. Purchase of investments was USD 13.444 million compared to USD 31.591 million a year ago. Adjusted net income was USD 11.800 million compared to USD 8.346 million a year ago. Adjusted EBITDA was USD 13.331 million compared to adjusted LBITDA of USD 10.959 million a year ago. The company revised financial guidance for the full year of 2015. The company increased 2015 revenue guidance in the range of USD 230 million to USD 235 million or approximately 35% growth year-over-year. The company expects gross profit margin of approximately 71% of total revenue, stock-based compensation, depreciation, and amortization expense of approximately 7% of total revenue and adjusted EBITDA margin in the range of 7% to 8% of total revenue. In order to help bridge to adjusted EBITDA metric, the company is following expenses: depreciation and amortization of approximately USD 3 million.

ZELTIQ Aesthetics, Inc. Presents at BTIG Medical Technology, Diagnostics and Healthcare IT Conference, Feb-18-2015

ZELTIQ Aesthetics, Inc. Presents at BTIG Medical Technology, Diagnostics and Healthcare IT Conference, Feb-18-2015 . Venue: Cliff Lodge Snowbird Ski &Summer Resort, Snowbird, Utah, United States.

ZELTIQ Aesthetics, Inc. to Report Q4, 2014 Results on Mar 03, 2015

ZELTIQ Aesthetics, Inc. announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Mar 03, 2015

Similar Private Companies By Industry

Company Name Region
CardioSolv Inc. United States
Continental HomeCare, Inc. United States
Icare Industries, Inc. United States
Occupational Marketing, Inc. United States
Seabrook International, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZELTIQ Aesthetics, Inc., please visit www.coolsculpting.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.